Chatchakorn Eurtivong, Ph.D.

ASCII���Hisilicon Balong
Affiliation Chemical Biology
Office CGI Building, 6th Floor, Office 15
Laboratory -
Telephone +66 2 5541900 Ext. 2635
Fax +66 2 5541990-1
E-mail chatchakorn@cgi.ac.th

Education

2009 - 2012B.Sc. in Chemistry The University of Auckland, New Zealand
2013 - 2014B.Sc. (Hons) in Medicinal Chemistry The University of Auckland, New Zealand
2014 - 2017Ph.D. in Computational ChemistryThe University of Auckland, New Zealand

Research Interests

  • Applications of in silico tools in drug discovery and development.
  • Virtual Screening for novel active compounds.
  • Computer-aided drug design.
  • Molecular docking and Molecular dynamics simulations.
  • Applications of chemoinformatics in drug development.

Publications

  1. Eurtivong, C.; Reynisdóttir, I.; Kuczma, S.; Furkert, D. P.; Brimble, M. A.; Reynisson, J., Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds. Bioorg. Med. Chem. 2016, 24 (16), 3521-3526.
  2. Eurtivong, C.; Semenov, V.; Semenova, M.; Konyushkin, L.; Atamanenko, O.; Reynisson, J.; Kiselyov A., 3-amino-theino[2,3-b]pyridines as microtubule-destabilizing agents: Molecular modelling and biological evaluation in the sea urchin embryo and human cancer cells. Bioorg. Med. Chem. 2017, 25 (2), 658-664.
  3. van Rensburg, M.; Leung, E.; Haverkate, N. A.; Eurtivong, C.; Pilkington, L. I.; Reynisson J.; Barker, D., Synthesis and antiproliferative activity of 2-chlorophenyl carboxamide thienopyridines. Bioorg. Med. Chem. Lett. 2017, 27 (2), 135-138.
  4. Bishit, R.; Jaiswal, J. K.; Oliver, V. F.; Eurtivong, C.; Reynisson, J.; Rupenthal, I. D., Preparation and evaluation of PLGA nanoparticle-loaded biodegradable light-responsive injectable implants as a promising platform for intravitreal drug delivery. J. Drug Deliv. Sci. Technol. 2017, 40, 142-156.
  5. Plażuk, D.; Wieczorek, A.; Ciszewski, W. M.; Kowalczyk, K.; Błauż, A.; Pawlędzio, S.; Makal, A.; Eurtivong, C.; Arabshahi, H. J.; Reynisson, J.; Hartinger, C. G.; Rychlik, B., A decoration of the side-chain of paclitaxel by ferrocenyl moiety and its influence on the cytotoxic activity of taxanes. ChemMedChem. 2017, 12 (22), 1882-1892.
  6. Zakharova, O.; Luzina, O.; Zakharenko, A.; Sokolov, D.; Filimonov, A.; Dyrkheeva, N.; Chepanova, A.; Ilina, E.; Ilyina, A.; Klabenkova, K.; Chelobanov, B.; Stetsenko, D.; Zafar, A.; Eurtivong, C.; Reynisson, J.; Volcho, K.; Salakhutdinov, N.; Lavrik, O., Synthesis and evaluation of aryliden- and hetarylidenfuranone derivatives of usnic acid as highly potent Tdp1 inhibitors. Bioorg. Med. Chem. 2018, 26(15), 4470-4480.
  7. Nilsu, T.; Thaisaeng, W.; Thamnarak, W.; Eurtivong, C.; Jumraksa, A.; Thorroad, S.; Khunnawutmanotham, N.; Ruchirawat, S.; Thasana, N., Three Lycopodium alkaloids from Thai club mosses. Phytochemistry. 2018, 156, 83-88.
  8. Eurtivong, C. ; Reynisson, J., The Development of a Weighted Index to Optimise Compound Libraries for High Throughput Screening. Mol. Inform. 2018, 38(3), DOI: 10.1002/minf.201800068.
  9. Obounchoey, P.; Tabtimmai, L.; Suphakun, P.; Thongkhao, K.; Eurtivong, C.; Gleeson, M. P.; Choowongkomon, K., In silico identification and in vitro validation of nogalamycin N-oxide (NSC116555) as a potent anticancer compound against non-small-cell lung cancer cells. J. Cell. Biochem. 2019, 120(3), 3353-3361.
  10. Tran, L. T.; Blay, V.; Luang, S.; Eurtivong, C.; Choknud, S.; Gonzalez-Diaz, H.; Ketudat Cairns J. R. Engineering Faster Transglycosidases and their Acceptor Specificity. Green Chem. 2019, 21 (10), DOI: 10.1039/C9GC00621D.
  11. Thongnest, S.; Chawengrum, P.; Keeratichamroen, S.; Lirdprapamongkol, K.; Eurtivong, C.; Boonsombat, J.; Kittakoop, P.; Svasti, J.; Ruchirawat, S., Vernodalidimer L, a sesquiterpene lactone dimer from Vernonia extensa and anti-tumor effects of vernodalin, vernolepin, and vernolide on HepG2 liver cancer cells. Bioorg. Chem. 2019, 92:103197
  12. Leung, E.; Pilkington, L. I.; Naiya, M. M.; Barker, D.; Zafar, A.; Eurtivong, C.; Reynisson, J., The cytotoxic potential of cationc triangulenes against tumour cells. MedChemComm. 2019, DOI: 10.1039/C9MD00305C